Paper36355409
A new software tool for computer assisted in vivo high-content analysis of transplanted fluorescent cells in intact zebrafish larvae.
Førde JL and 4 others. Biol Open, 2022. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. A new software tool for computer assisted in vivo high-content analysis of transplanted fluorescent cells in intact zebrafish larvae. Papers, record 36355409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36355409
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A new software tool for computer assisted in vivo high-content analysis of transplanted fluorescent cells in intact zebrafish larvae.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Zebrafish | Major topic |
| Image Processing, Computer-Assisted | Major topic |
| Animals | |
| Larva | |
| Software | |
| Computers |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| F-12533 | null | PubMed | ||
| 82845 | NordForsk | PubMed | ||
| 180007 | Barnekreftforeningen | PubMed | ||
| Astri og Edvard Riisøens legat | PubMed | |||
| University of Bergen: Universitetet i Bergen | PubMed |
Source PubMed
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19230772 | Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. | Lancet Oncol | 2009 | https://conductscience.org/library/papers/19230772 | PubMed |
| 2 | 23681123 | TANGO: a generic tool for high-throughput 3D image analysis for studying nuclear organization. | Bioinformatics | 2013 | https://conductscience.org/library/papers/23681123 | PubMed |
| 3 | 33423844 | Current and emerging strategies for management of myelodysplastic syndromes. | Blood Rev | 2021 | https://conductscience.org/library/papers/33423844 | PubMed |
| 4 | 33757574 | Emerging agents and regimens for AML. | J Hematol Oncol | 2021 | https://conductscience.org/library/papers/33757574 | PubMed |
| 5 | 33340278 | Zebrafish models of acute leukemias: Current models and future directions. | Wiley Interdiscip Rev Dev Biol | 2021 | https://conductscience.org/library/papers/33340278 | PubMed |
| 6 | 20711990 | Hematopoietic development in the zebrafish. | Int J Dev Biol | 2010 | https://conductscience.org/library/papers/20711990 | PubMed |
| 7 | 18371439 | Transparent adult zebrafish as a tool for in vivo transplantation analysis. | Cell Stem Cell | 2008 | https://conductscience.org/library/papers/18371439 | PubMed |
| 8 | 23307606 | Human cardiotoxic drugs delivered by soaking and microinjection induce cardiovascular toxicity in zebrafish. | J Appl Toxicol | 2014 | https://conductscience.org/library/papers/23307606 | PubMed |
| 9 | 23733750 | Patient-derived tumor xenografts: transforming clinical samples into mouse models. | Cancer Res | 2013 | https://conductscience.org/library/papers/23733750 | PubMed |
| 10 | 26376137 | Acute Myeloid Leukemia. | N Engl J Med | 2015 | https://conductscience.org/library/papers/26376137 | PubMed |
| 11 | 29436122 | The zebrafish: A fintastic model for hematopoietic development and disease. | Wiley Interdiscip Rev Dev Biol | 2018 | https://conductscience.org/library/papers/29436122 | PubMed |
| 12 | 20513764 | Metadata matters: access to image data in the real world. | J Cell Biol | 2010 | https://conductscience.org/library/papers/20513764 | PubMed |
| 13 | 29933727 | Azacitidine-associated pleuropericardial effusion in myelodysplastic syndrome: A case report. | J Oncol Pharm Pract | 2019 | https://conductscience.org/library/papers/29933727 | PubMed |
| 14 | 22930834 | NIH Image to ImageJ: 25 years of image analysis. | Nat Methods | 2012 | https://conductscience.org/library/papers/22930834 | PubMed |
| 15 | 28129840 | Infectious disease models in zebrafish. | Methods Cell Biol | 2017 | https://conductscience.org/library/papers/28129840 | PubMed |
| 16 | 9305600 | Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11;9)(q23;p22p23). | Leukemia | 1997 | https://conductscience.org/library/papers/9305600 | PubMed |
| 17 | 12481136 | Heart regeneration in zebrafish. | Science | 2002 | https://conductscience.org/library/papers/12481136 | PubMed |
| 18 | 35158142 | Pharmacological assessment of zebrafish-based cardiotoxicity models. | Biomed Pharmacother | 2022 | https://conductscience.org/library/papers/35158142 | PubMed |
| 19 | 32997910 | Myelodysplastic Syndromes. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32997910 | PubMed |
| 20 | 26940554 | Azacitidine-Induced Pericarditis: A Case Series. | Pharmacotherapy | 2016 | https://conductscience.org/library/papers/26940554 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41590749 | Marine Bromophenols from Laminaria hyperborea's Epiphytic Biomass: Chemical Profiling, Cytotoxicity, and Antioxidant Activity. | Mar Drugs | 2026 | https://conductscience.org/library/papers/41590749 | PubMed |
| 41353995 | Phenazine 5,10-dioxide analogues as potential therapeutics in AML: Efficacy on patient-derived blasts, in zebrafish larvae xenografts and synergy with venetoclax. | Transl Oncol | 2026 | https://conductscience.org/library/papers/41353995 | PubMed |
| 38185059 | The Rac1-inhibitor EHop-016 attenuates AML cell migration and enhances the efficacy of daunorubicin in MOLM-13 transplanted zebrafish larvae. | Transl Oncol | 2024 | https://conductscience.org/library/papers/38185059 | PubMed |
| 38110013 | Development of nanoparticles based on amphiphilic cyclodextrins for the delivery of active substances. | Int J Pharm | 2024 | https://conductscience.org/library/papers/38110013 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CXADRP1 | 653108 | PubTator's text mining | https://conductscience.org/library/genes/653108 | NCBI Gene |
| IDH2 | 3418 | PubTator's text mining | https://conductscience.org/library/genes/3418 | NCBI Gene |
| IL3 | 3562 | PubTator's text mining | https://conductscience.org/library/genes/3562 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36355409
GET https://conductscience.org/api/papers/v1/36355409/references?page=2